10-Q: Pyxus Q2 Sees Sales Rise, Net Loss Narrows Amid Higher Processing Volumes

Pyxus International reported a slight increase in Q2 sales and a reduced net loss, driven by higher processing volumes and improved gross margins, despite a year-to-date sales decline.

Summary

• Sales and other operating revenues for the three months ended September 30, 2025, increased by 0.7% to $570.2 million, compared to $566.3 million in the prior year.
• Gross profit for the three months ended September 30, 2025, rose by 16.4% to $87.8 million, up from $75.4 million in the prior year, with gross margin as a percent of sales increasing to 15.4% from 13.3%.
• Net loss attributable to Pyxus International, Inc. for the three months ended September 30, 2025, significantly narrowed to $0.9 million, from a loss of $3.2 million in the comparable prior-year period.
• Diluted earnings per share improved to a loss of $0.03 for the three months ended September 30, 2025, compared to a loss of $0.12 in the prior year.
• For the six months ended September 30, 2025, sales and other operating revenues decreased by 10.2% to $1,079.0 million, down from $1,201.2 million in the prior year, primarily due to a 12.9% decline in kilo volumes sold.
• Net loss attributable to Pyxus International, Inc. for the six months ended September 30, 2025, was $16.7 million, a significant shift from net income of $1.4 million in the prior year.
• Net cash used in operating activities for the six months ended September 30, 2025, increased substantially to $580.9 million, compared to $280.3 million in the prior year, mainly to fund purchases of larger crops.
• Total debt increased to $1,363.3 million as of September 30, 2025, from $1,234.3 million as of September 30, 2024.
• Total tobacco inventory stood at $1,102.8 million as of September 30, 2025, with unprocessed tobacco increasing significantly.

Sentiment

Score: 4

Explanation: While the company showed improved gross profit and a narrowed net loss for the three-month period, the six-month results reveal a significant decline in sales and a substantial shift from net income to a net loss. The considerable increase in cash used in operating activities and rising net debt indicate significant liquidity demands, despite increased borrowing capacity. The new risk factor regarding e-liquid product liability adds a layer of uncertainty. The overall financial health, particularly the cash burn and debt levels, presents a cautious outlook.

Positives

• Three-month sales increased by 0.7% to $570.2 million, driven by higher volumes and processing revenues.
• Gross profit for the three months increased by 16.4% to $87.8 million, with gross margin as a percent of sales improving to 15.4% from 13.3%.
• Net loss for the three months significantly narrowed to $0.9 million from $3.2 million in the prior year.
• Operating income for the three months increased by 41.5% to $46.7 million.
• Average cost per kilo for leaf product sales decreased by 7.9% due to lower inventory costs of current crops in Africa and South America.
• ABL Credit Facility commitments increased to $150.0 million and maturity extended to May 12, 2030.
• Foreign seasonal lines of credit total borrowing capacity increased by $182.2 million to $1,067.4 million, providing more funding for green tobacco purchases.
• The company was in compliance with all covenants under its ABL Credit Agreement, Intabex Term Loan Credit Agreement, Pyxus Term Loan Credit Agreement, 2027 Notes Indenture, and short-term seasonal lines of credit.
• Uncommitted levels of processed tobacco remain low due to steady customer demand.
• More favorable weather conditions have resulted in larger crops harvested, particularly in Africa and South America, which is anticipated to provide a more balanced market position.

Negatives

• Net loss attributable to Pyxus International, Inc. for the six months ended September 30, 2025, was $16.7 million, a significant decline from net income of $1.4 million in the prior year.
• Sales and other operating revenues for the six months ended September 30, 2025, decreased by 10.2% to $1,079.0 million, primarily due to a 12.9% decline in kilo volumes sold.
• Operating income for the six months decreased by 7.9% to $67.7 million.
• Net cash used in operating activities for the six months ended September 30, 2025, significantly increased to $580.9 million from $280.3 million in the prior year, indicating higher cash burn.
• Working capital declined by $16.0 million, or 4.1%, to $371.6 million as of September 30, 2025, compared to $387.6 million in the prior year.
• Net debt increased to $1,264.1 million as of September 30, 2025, from $1,110.9 million in the prior year.
• The company did not benefit from gains on debt retirement in the current period, unlike the prior year which saw $6.9 million (3 months) and $8.2 million (6 months) from debt repurchases.
• $80.5 million of cash is held in non-U.S. jurisdictions, subject to exchange controls and potential tax consequences upon repatriation, limiting full access to these funds.
• Income tax expense for the three months ended September 30, 2025, increased by 27.2% to $10.3 million, primarily due to foreign currency gains and jurisdictional mix of earnings.
• Income tax expense for the six months ended September 30, 2025, increased by 9.2% to $15.5 million, due to foreign currency gains and an increase in the liability for unrecognized tax benefits.
• Net (loss) income from unconsolidated affiliates for the six months ended September 30, 2025, was a loss of $0.7 million, compared to income of $3.1 million in the prior year.

Risks

• Reliance on a small number of significant customers.
• Continued vertical integration by customers.
• Global shifts in sourcing customer requirements, imposition of tariffs, and changes in international trade policies.
• Shifts in the global supply and demand position for tobacco products.
• Variation in financial results due to growing conditions, customer indications, and other factors.
• Loss of confidence by customers, farmers, and other suppliers.
• Migration of tobacco suppliers toward growing other crops.
• Risks related to advancing inputs to tobacco suppliers to be settled upon delivery of unprocessed tobacco.
• Risks that purchased tobacco will not meet customer quality and quantity requirements.
• Weather and other environmental conditions affecting inventory quantity and marketability.
• International business risks, including unsettled political conditions, uncertainty in legal obligation enforcement, fraud risks, expropriation, import/export restrictions, exchange controls, inflationary economies, currency risks, and restrictions on repatriation of earnings.
• Operations in jurisdictions with high risk of Foreign Corrupt Practices Act violations.
• Risks and uncertainties related to geopolitical conflicts, including in the Middle East and shipping disruptions.
• Impacts of international sanctions on ability to sell or source tobacco.
• Exposure to foreign tax regimes with unclear, inconsistently applied, and suddenly changing rules.
• Fluctuations in foreign currency exchange and interest rates.
• Competition with the other primary global independent leaf tobacco merchant and independent leaf merchants.
• Disruption, failure, or security breaches of information technology systems and other cybersecurity risks.
• Continued high inflation.
• Regulations regarding environmental matters.
• Risks related to significant debt and ability to finance non-U.S. local operations with uncommitted short-term operating credit lines.
• Ability to continue to access capital markets for financing.
• Potential failure of foreign banks where subsidiaries maintain deposits or failure to transfer funds/honor withdrawals.
• Inability to generate significant cash required to service indebtedness.
• Ability to refinance current credit facilities at the same availability or at similar or reduced interest rates.
• Failure to achieve stated goals, adversely affecting liquidity.
• Volatility and disruption of global credit markets.
• Failure by counterparties to derivative transactions to perform their obligations.
• Increasing scrutiny and changing expectations from governments, as well as other stakeholders such as investors and customers, with respect to environmental, social and governance policies, including sustainability policies.
• Inherent risk of exposure to product liability claims, regulatory action, and litigation if products are alleged to have caused significant loss, injury, or death, particularly for e-liquid and consumable nicotine products.
• Certain shareholders have the ability to exercise controlling influence on various corporate matters.
• Reductions in demand for consumer tobacco products.
• Risks and uncertainties related to pandemics or other widespread health crises and any related shipping constraints, labor shortages and supply-chain impacts.
• Legislative and regulatory initiatives that may reduce consumption of consumer tobacco products and demand for services and increase regulatory burdens.
• Government actions that significantly affect the sourcing of tobacco, including governmental actions to identify and assess crop diversification initiatives and alternatives to leaf tobacco growing in countries whose economies depend upon tobacco production.
• Governmental investigations into the Company's business activities, including but not limited to, leaf tobacco industry buying and other payment practices.
• Impact of proposed regulations to prohibit the sale of cigarettes and certain other tobacco products in the United States other than low-nicotine versions of those products.
• Brazilian tax assessment of $10.82 million (including penalties and interest) for intrastate trade tax credits, which if lost, would have a material impact.
• Product liability insurance for e-liquid and consumable nicotine products may not be maintained on acceptable terms or with adequate coverage, or may not be available in the future.

Future Outlook

The company anticipates periods during which its liquidity needs for operations will approach the levels of available cash and permitted borrowings, and while current sources are believed sufficient for the next twelve months, unanticipated developments could lead to a deficiency. More favorable weather conditions have resulted in larger crops harvested, particularly in Africa and South America, which is expected to provide a more balanced global tobacco market position through the remainder of the fiscal year. The company expects to incur an additional $16.4 million in capital expenditures and $2.4 million in pension and postretirement contributions for the remainder of the fiscal year ending March 31, 2026.

Management Comments

• Our second quarter results and financial condition reflect the impact of larger crops from our origins in the Southern hemisphere.
• Our total tobacco inventory balance, comprised of both processed and unprocessed tobacco, stands at $1,102.8 million as of September 30, 2025, which will enable us to meet our customers' requirements for leaf that we have sourced from our wide network of growers across the globe.
• Although we believe that our sources of liquidity will be sufficient to fund our anticipated operating needs for the next twelve months, we anticipate periods during which our liquidity needs for operations will approach the levels of our anticipated available cash and permitted borrowings under our credit facilities.
• We continuously monitor and, as available, adjust funding sources as needed to enhance and drive various business opportunities.
• We will continue to monitor and hedge foreign currency costs, as needed.

Industry Context

The global tobacco market has experienced undersupply conditions in recent periods, but Pyxus International notes that more favorable weather conditions have led to larger crops in Africa and South America. This is anticipated to create a more balanced market position for the remainder of the fiscal year. The company's business is highly seasonal, with working capital requirements peaking in the first half of the fiscal year, coinciding with the buying season in key sourcing regions. The company's focus on responsibly sourced, independently verified, sustainable, and traceable products aligns with increasing industry and stakeholder demands for ESG policies.

Corporate Governance

Legal Proceedings

• Brazilian Tax Credits: The government in the Brazilian State of Parana issued a tax assessment on October 26, 2007, for $2,482k in intrastate trade tax credits, with a total assessment including penalties and interest of $10,820k. The company believes it has complied with Brazilian law and will contest the assessment, but a loss would have a material impact on financial statements.
• Other Litigation: The company and its subsidiaries are involved in other litigation or legal matters incidental to their business activities, including tax matters. While outcomes are uncertain, the company does not currently expect a material adverse effect, but an adverse resolution could be material for a particular fiscal reporting period.
• Product Liability for E-liquids: Joint ventures manufacturing e-liquid and consumable nicotine-related products face inherent risk of exposure to product liability claims, regulatory action, and litigation if products are alleged to have caused injury, harm, or death, or due to tampering/contamination. This risk is significant, particularly in the U.S., and insurance may not be sufficient or available.

Related Party Transactions

• Monarch Alternative Capital LP (24.9% beneficial ownership) has a designated director on the board. In 2024, Pyxus Holdings repurchased $77,922k of 2027 Notes for $60,000k (23.0% discount) and $10,345k of Pyxus Term Loans for $9,104k (12.0% discount) from Monarch-affiliated funds. Monarch is no longer a holder of 2027 Notes and Pyxus Term Loans but remains a related party as a holder of Intabex Term Loans and a significant common stock owner.
• Glendon Capital Management, L.P. (33.8% beneficial ownership) has a representative serving as a director.
• Owl Creek Asset Management, L.P. (15.7% beneficial ownership) manages funds that were holders of Intabex Term Loans, Pyxus Term Loans, and 2027 Notes.
• Interest payable to Investor-Affiliated Funds (including Glendon, Monarch, Owl Creek) and CI Investments was $1,403k as of September 30, 2025.
• Interest expense related to Investor-Affiliated Funds and CI Investments was $5,510k for the three months and $10,976k for the six months ended September 30, 2025.
• On August 21, 2024, the company repurchased 392k shares of its common stock for approximately $1,000k from CI Investments, Inc., which was a beneficial owner of greater than five percent of the company's common stock at that time.

Stakeholder Impact

• Shareholders: Experienced a net loss for the six-month period and diluted EPS of $(0.65), a significant decline from prior year income. Dividends are restricted by debt agreements. Share repurchase program is authorized but limited.
• Employees: Equity-based compensation is a component of remuneration, with unrecognized compensation cost of $1,430k for restricted stock units.
• Customers: The company aims to meet customer requirements with its $1,102.8 million tobacco inventory. Steady demand keeps uncommitted processed tobacco levels low.
• Suppliers (Tobacco Farmers): The company guarantees bank loans for tobacco suppliers to finance crops, with amounts guaranteed increasing to $86,958k. Advances to tobacco suppliers increased.
• Creditors: Total debt increased to $1.36 billion. The company is in compliance with debt covenants, but liquidity needs are high, and the ability to refinance debt is a risk. Interest expense is significant.
• Regulatory Authorities: The company faces a material Brazilian tax assessment and new risks related to product liability claims for e-liquids, which could lead to regulatory action.

Next Steps

• Continue to monitor and hedge foreign currency costs.
• Incur an additional $16.4 million in capital expenditures for the remainder of the fiscal year ending March 31, 2026.
• Make an additional $2.4 million in contributions to pension and postretirement health and life insurance benefits for the remainder of the fiscal year ending March 31, 2026.
• Contest the Brazilian tax assessment through the judicial process.
• Evaluate the impact of ASU No. 2025-06 on financial condition, results of operations, and cash flows.
• Potentially undertake plans to minimize cash outflows, including exiting operations that do not generate positive cash flow, to address potential liquidity deficiencies.
• Potentially purchase, redeem, repay, retire, or cancel indebtedness prior to stated maturity or refinance debt, depending on market conditions and compliance with debt covenants.

Key Dates

Recommendation

While Pyxus International demonstrated improved gross margins and a narrowed net loss in the most recent quarter, the year-to-date performance shows a significant decline in sales and a shift to a net loss, coupled with a substantial increase in cash used in operations and higher net debt. The company's liquidity position, though supported by increased borrowing capacity, remains tight given its seasonal business and high working capital requirements. The new risk factor concerning product liability for e-liquids adds a layer of uncertainty. The company is managing its debt and operations, but the overall financial trajectory for the first half of the fiscal year suggests caution. A 'hold' recommendation is appropriate as the company navigates its high debt load and operational challenges, with some positive signs in Q2 but significant headwinds year-to-date.

Keywords

Tobacco, Leaf Tobacco, Agricultural Company, SEC Filing, 10-Q, Financial Results, Quarterly Report, Pyxus International, PYX, Earnings, Revenue, Net Loss, Gross Profit, Debt, Liquidity, Working Capital, Inventories, Foreign Currency Risk, Product Liability, E-liquids, Consumable Nicotine, Corporate Governance, Related Party Transactions, Risk Factors, Brazil Tax Credits